Atlas Trials

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

Clinical trial NCT04448717 · COMPLETED

Trial details

NCT number
NCT04448717
Sponsor
University of Zurich
Status
COMPLETED
Study type
OBSERVATIONAL
SARS-CoV 2COVID-19
Start date
2020-06-16
Primary completion
2022-07-20
Enrollment
4250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.